CLINICAL_TRIALS
trial_result
· 2021-09-02
Clinical Trial Update: Menstrual Blood Stem Cells in Severe Covid-19 [Phase 1, Phase 2]
Summary
A Phase 1/2 trial investigating menstrual blood–derived stem cells for severe COVID-19 with cytokine storm has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avicenna Research Institute | Conditions: Covid19, Cytokine Storm | Phase 1, Phase 2 | Status: COMPLETED